Labocanna

Labocanna Gross Profit/Assets

The Gross Profit to Assets Ratio of Labocanna (LCN.WA) as of Oct 17, 2026 is 2.96 %. In the previous year, Gross Profit to Assets Ratio was 2.51 % — a change of 17.71% (higher).

Gross Profit/Assets

2.96 %

YoY

17.71%

Last updated:

Gross Profit to Assets Ratio of Labocanna is 2025 2.96 % . Gross Profit to Assets Ratio of Labocanna was 2024 2.51 % . It decreases by 17.71% higher compared to the previous year.

The Labocanna Gross Profit/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit/Assets
Date
Gross Profit/Assets
Jan 1, 2018
108.07 PLN
Jan 1, 2019
6.45 PLN
Jan 1, 2020
3.20 PLN
Jan 1, 2021
1.94 PLN
Jan 1, 2022
-0.23 PLN
Jan 1, 2023
-0.07 PLN
Jan 1, 2024
2.51 PLN
Jan 1, 2025
2.96 PLN
The Labocanna Gross Profit/Assets history
YEARGross Profit/AssetsYoY
2.96 %+17.71%
2.51 %-3,847.63%
-0.07 %-71.12%
-0.23 %-111.99%
1.94 %-39.50%
3.20 %-50.40%
6.45 %-94.03%
108.07 %-30.52%
155.56 %+26.46%
123.01 %+19.24%
103.16 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

Gross Profit to Assets Ratio of Labocanna is 2.96 % in 2025.

Gross Profit to Assets Ratio of Labocanna changed from 2.51 % to 2.96 %, representing a 17.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit to Assets Ratio Labocanna since 2006 – with annual values, charts, and detailed analysis.

Gross Profit/Assets measures how efficiently a company uses its assets to generate gross profit. Research shows it is a strong predictor of future stock returns.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Profit to Assets Ratio's Labocanna with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Profit to Assets Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Profit to Assets Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Labocanna

All Key Metrics — Labocanna